FAM
RVMD icon

Fred Alger Management’s Revolution Medicines RVMD Stock Holding History

Fred Alger Management’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$48.6M Buy
259,468
+238,094
+1,114% +$34.8M 0.16% 67
2026
Q1 		$2.08M Buy
21,374
+5,124
+32% +$517K 0.01% 315
2025
Q4 		$1.29M Sell
16,250
-100,530
-86% -$6.59M 0.01% 343
2025
Q3 		$5.45M Buy
116,780
+135
+0.1% +$5.29K 0.02% 233
2025
Q2 		$4.29M Sell
116,645
-754
-0.6% -$29K 0.02% 249
2025
Q1 		$4.15M Sell
117,399
-30,727
-21% -$1.25M 0.02% 238
2024
Q4 		$6.48M Sell
148,126
-392,547
-73% -$19.8M 0.03% 216
2024
Q3 		$24.5M Buy
540,673
+518,909
+2,384% +$22.6M 0.12% 124
2024
Q2 		$845K Buy
+21,764
New +$813K ﹤0.01% 361
2023
Q4 		– Sell
-4,542
Closed -$126K – 488
2023
Q3 		$126K Buy
+4,542
New +$135K ﹤0.01% 416

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Fred Alger Management's RVMD Position: Q2 2026 in Review

Fred Alger Management increased its Revolution Medicines (RVMD) stake by 1,114% in Q2 2026, buying an estimated $34.8M and bringing the position to 259,468 shares worth $48.6M. The position accounts for 0.16% of the portfolio, ranked #67.

Fred Alger Management first reported a position in RVMD in Q3 2023 and has held it in 10 quarters since. 690 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Fred Alger Management held 259,468 shares of Revolution Medicines worth $48.6M as of Q2 2026.
  • Fred Alger Management bought 238,094 Revolution Medicines shares in Q2 2026, an estimated $34.8M.
  • Revolution Medicines made up 0.16% of Fred Alger Management's portfolio in Q2 2026, its #67 holding.
  • Fred Alger Management first reported a position in Revolution Medicines in Q3 2023 and has held it in 10 quarters since.
  • 690 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Fred Alger Management's 13F filing for Q2 2026, filed 14 Aug 2026.